Korean J Gastroenterol.
2008 Jul;52(1):59-63.
Salvage Chemotherapy after Gemcitabine Failure in Patients with Advanced Pancreatic Cancer: Survival Benefit in Selected Patients
- Affiliations
-
- 1Division of Gastroenterology, Department of Internal Medicine, Asan Medical Center, Seoul, Korea.
- 2Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Abstract
- No abstract available.
MeSH Terms
-
Angiogenesis Inhibitors/therapeutic use
Antibodies, Monoclonal/therapeutic use
Antimetabolites, Antineoplastic/*therapeutic use
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Deoxycytidine/*analogs & derivatives/therapeutic use
Drug Resistance, Neoplasm
Humans
Pancreatic Neoplasms/*drug therapy/mortality/pathology
*Salvage Therapy
Survival Analysis
Treatment Failure
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Chemotherapy for Pancreatic Cancer
- Second Line Chemotherapy for Pancreatic Cancer
- The clinical outcomes of second-line chemotherapy in patients with advanced pancreatic cancer: a retrospective study
- Long Term Complete Response of Unresectable Locally Advanced Pancreatic Cancer after CCRT and Gemcitabine Chemotherapy
- A Phase II Study of Combination Chemotherapy with Gemcitabine, 5-fluorouracil, and Cisplatin for Advanced Pancreatic Cancer
